Bakterielle Infektionen bei Neugeborenen. Leitlinie der GNPI, DGPI, DGKJ und DGGG. (S2k-Level, AWMF-Leitlinien-Register-Nr. 024/008, April 2018)

Michael Zemlin; Angelika Berger; Axel Franz; Christian Gille; Christoph Härtel; Helmut Küster; Andreas Müller; Frank Pohlandt; Arne Simon; Waltraud Merz

doi:10.1055/a-0756-7338

Zeitschrift für Geburtshilfe und Neonatologie, Table of Contents

Z Geburtshilfe Neonatol 2019; 223(03): 130-144
DOI: 10.1055/a-0756-7338

Leitlinie

Bakterielle Infektionen bei Neugeborenen. Leitlinie der GNPI, DGPI, DGKJ und DGGG. (S2k-Level, AWMF-Leitlinien-Register-Nr. 024/008, April 2018)

Michael Zemlin

¹Klinik für Allgemeine Pädiatrie und Neonatologie, Universitätsklinikum des Saarlandes, Homburg/Saar

,

Angelika Berger

²Universitätsklinik für Kinder- und Jugendheilkunde, Wien

,

Axel Franz

³Universitätsklinik für Kinder- und Jugendmedizin, Tübingen

,

Christian Gille

³Universitätsklinik für Kinder- und Jugendmedizin, Tübingen

,

Christoph Härtel

⁴Universitätsklinik für Kinder- und Jugendmedizin, Lübeck

,

Helmut Küster

⁵Georg-August-Universität Göttingen

,

Andreas Müller

⁶Zentrum für Kinderheilkunde, Universitätsklinikum Bonn

,

Frank Pohlandt

⁷ehemaliger Leiter der Neonatologie der Universitätsklinik Ulm

,

Arne Simon

⁸Klinik für Pädiatrische Onkologie und Hämatologie Universitätsklinikum des Saarlandes, Homburg/Saar

,

Waltraud Merz

⁹Abteilung für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Bonn

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Wynn JL, Wong HR, Shanley TP. et al. Time for a neonatal-specific consensus definition for sepsis. Pediatric critical care medicine: A journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2014; 15: 523-528
2 AWMF. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S2k-Leitlinie 024-020 “Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B”. 2016 [updated 2016/03/09. Available from http://www.awmf.org/leitlinien/detail/ll/024-020.html http://www.awmf.org/leitlinien/detail/ll/024-020.html
3 Schwab F, Zibell R, Piening B. et al. Mortality due to bloodstream infections and necrotizing enterocolitis in very low birth weight infants. The Pediatric infectious disease journal 2015; 34: 235-240.
4 RKI. Robert Koch-Institut. Definitionen nosokomialer Infektionen (CDC-Definitionen). 7 ed: NRZ Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen 2011
5 Garner JS, Jarvis WR, Emori TG. et al. CDC definitions for nosocomial infections. American journal of infection control 1988; 16: 128-140.
6 NRZ. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen. KISS (Krankenhaus-Infektions-Surveillance-System). updated 2015/04/16. Available from http://www.nrzhygiene.de/surveillance/kiss/
7 Ussat M, Vogtmann C, Gebauer C. et al. The role of elevated central-peripheral temperature difference in early detection of late-onset sepsis in preterm infants. Early human development 2015; 91: 677-681
8 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
9 Weston EJ, Pondo T, Lewis MM. et al. The burden of invasive earlyonset neonatal sepsis in the United States, 2005–2008. The Pediatric infectious disease journal 2011; 30: 937-941
10 Wynn JL, Hansen NI, Das A. et al. Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. J Pediatr 2013; 162: 942-8.e1-3
11 NRZ. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen. NEO-KISS (Surveillance System nosokomialer Infektionen für Frühgeborene auf Intensivstationen).updated 2015/04/16. Available from http://www.nrz-hygiene.de/surveillance/kiss/neo-kiss/
12 Puopolo KM, Draper D, Wi S. et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011; 128: e1155-e1163
13 Didier C, Streicher MP, Chognot D. et al. Late-onset neonatal infections: Incidences and pathogens in the era of antenatal antibiotics. European journal of pediatrics 2012; 171: 681-687
14 Hornik CP, Fort P, Clark RH. et al. Early and late onset sepsis in verylow-birth-weight infants from a large group of neonatal intensive care units. Early human development 2012; 88 (Suppl. 02) S69-S74
15 Zaidi AK, Knaut AL, Mirrett S. et al. Value of routine anaerobic blood cultures for pediatric patients. J Pediatr 1995; 127: 263-268
16 Stoll BJ, Hansen NI, Sanchez PJ. et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127: 817-826
17 Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. The Lancet Infectious diseases 2003; 3: 201-213
18 Geffers C, Haller S, Heller G. et al. Nosokomiale Infektionen bei Neugeborenen. Monatsschr Kinderheilkd 2014; 162: 385-393
19 Hartel C, Faust K, Avenarius S. et al. Epidemic microclusters of bloodculture proven sepsis in very-low-birth weight infants: Experience of the German Neonatal Network. PloS one 2012; 7: e38304
20 Tsai MH, Chu SM, Hsu JF. et al. Risk factors and outcomes for multidrugresistant Gram-negative bacteremia in the NICU. Pediatrics 2014; 133: e322-e329
21 Dong Y, Speer CP. Late-onset neonatal sepsis: Recent developments. Arch Dis Child Fetal Neonatal Ed 2015; 100: F257-F263
22 van de Laar R, van der Ham DP, Oei SG. et al. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: A systematic review. European journal of obstetrics, gynecology, and reproductive biology 2009; 147: 124-129
23 Su H, Chang SS, Han CM. et al. Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis. Journal of perinatology: Official journal of the California Perinatal Association 2014; 34: 268-74
24 Kerste M, Corver J, Sonnevelt MC. et al. Application of sepsis calculator in newborns with suspected infection. The journal of maternal-fetal & neonatal medicine: The official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2016; 29: 3860-3865
25 Siriwachirachai T, Sangkomkamhang US, Lumbiganon P. et al. Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections. Cochrane Database Syst Rev 2014; Cd007772
26 Hutton EK, Thorpe J. Consequences of meconium stained amniotic fluid: What does the evidence tell us?. Early human development 2014; 90: 333-339
27 Modi N, Dore CJ, Saraswatula A. et al. A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child Fetal Neonatal Ed 2009; 94: F8-F12
28 Edwards MS, Baker CJ, Kaplan SL et al. Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants.: UpToDate 2016 Available from
29 Fairchild KD. Predictive monitoring for early detection of sepsis in neonatal ICU patients. Current opinion in pediatrics 2013; 25: 172-179
30 Sullivan BA, Grice SM, Lake DE. et al. Infection and other clinical correlates of abnormal heart rate characteristics in preterm infants. J Pediatr 2014; 164: 775-780
31 Franz AR, Kron M, Pohlandt F. et al. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. The Pediatric infectious disease journal 1999; 18: 666-771
32 Franz AR, Steinbach G, Kron M. et al. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104 3 Pt 1 447-453
33 Franz AR, Steinbach G, Kron M. et al. Interleukin-8: A valuable tool to restrict antibiotic therapy in newborn infants. Acta paediatrica (Oslo, Norway: 1992) 2001; 90: 1025-1032
34 Franz AR, Bauer K, Schalk A. et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: A multicenter, randomized, controlled trial. Pediatrics 2004; 114: 1-8
35 Franz AR, Sieber S, Pohlandt F. et al. Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection. Acta paediatrica (Oslo, Norway: 1992) 2004; 93: 648-653
36 Mathers NJ, Pohlandt F. Diagnostic audit of C-reactive protein in neonatal infection. European journal of pediatrics 1987; 146: 147-151
37 Ehl S, Gering B, Bartmann P. et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216-221
38 Benitz WE, Han MY, Madan A. et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102: E41
39 Philip AG, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: Experience with infants initially admitted to a well-baby nursery. Pediatrics 2000; 106: E4
40 Laborada G, Rego M, Jain A. et al. Diagnostic value of cytokines and Creactive protein in the first 24 hours of neonatal sepsis. American journal of perinatology 2003; 20: 491-501
41 Pourcyrous M, Bada HS, Korones SB. et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92: 431-435
42 Orlikowsky TW, Neunhoeffer F, Goelz R. et al. Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatric research 2004; 56: 804-809
43 Buck C, Bundschu J, Gallati H. et al. Interleukin-6: A sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994; 93: 54-58
44 Messer J, Eyer D, Donato L. et al. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996; 129: 574-580
45 Berner R, Niemeyer CM, Leititis JU. et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatric research 1998; 44: 469-477
46 Kuster H, Weiss M, Willeitner AE. et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet (London, England) 1998; 352: 1271-1277
47 Escobar GJ, Li DK, Armstrong MA. et al. Neonatal sepsis workups in infants>/=2000 grams at birth: A population-based study. Pediatrics 2000; 106 2 Pt 1 256-263
48 Chiesa C, Pellegrini G, Panero A. et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clinical chemistry 2003; 49: 60-68
49 Philip AG, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics 1980; 65: 1036-1041
50 Russell GA, Smyth A, Cooke RW. Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection. Arch Dis Child 1992; 67 (7 Spec No) 808-812
51 Doellner H, Arntzen KJ, Haereid PE. et al. Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 1998; 132: 295-299
52 Forestier F, Daffos F, Catherine N. et al. Developmental hematopoiesis in normal human fetal blood. Blood 1991; 77: 2360-2363
53 Walka MM, Sonntag J, Kage A. et al. Complete blood counts from umbilical cords of healthy term newborns by two automated cytometers. Acta haematologica 1998; 100: 167-173.
54 Segel GB, Halterman JS. Neutropenia in pediatric practice. Pediatrics in review 2008; 29: 12-23 quiz 4
55 Mouzinho A, Rosenfeld CR, Sanchez PJ. et al. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994; 94: 76-82
56 van der Meer W, van Gelder W, de Keijzer R. et al. Does the band cell survive the 21^st century?. European journal of haematology 2006; 76: 251-254
57 Newman TB, Puopolo KM, Wi S. et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126: 903-909
58 Kiser C, Nawab U, McKenna K. et al. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics 2014; 133: 992-998
59 Newman TB, Draper D, Puopolo KM. et al. Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: Use of the I/T2. The Pediatric infectious disease journal 2014; 33: 798-802
60 Jackson GL, Engle WD, Sendelbach DM. et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis?. Pediatrics 2004; 113: 1173-1180
61 Marchini G, Berggren V, Djilali-Merzoug R et al. The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta paediatrica. Oslo, Norway: 1992); 2000: 89: 1082–1086
62 Sola MC, Del Vecchio A, Rimsza LM. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clinics in perinatology 2000; 27: 655-679
63 Stocker M, Fontana M, El Helou S. et al. Use of procalcitonin-guided decisionmaking to shorten antibiotic therapy in suspected neonatal early-onset sepsis: Prospective randomized intervention trial. Neonatology 2010; 97: 165-174
64 Turner D, Hammerman C, Rudensky B. et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis. Digestive diseases and sciences 2007; 52: 2972-2976
65 Arnon S, Litmanovitz I, Regev RH. et al. Serum amyloid A: An early and accurate marker of neonatal early-onset sepsis. Journal of perinatology: Official journal of the California Perinatal Association 2007; 27: 297-302
66 Schelonka RL, Maheshwari A, Carlo WA. et al. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine 2011; 53: 249-255
67 Koch L, Fritzsching B, Frommhold D. et al. Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: Role of nuclear factor-kappa B and p38 MAPK. Neonatology 2011; 99: 140-145
68 National Collaborating Centre for Women’s and Children’s Health. National Institute for Health and Clinical Excellence: Guidance. Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection. London: RCOG Press 2012
69 Dien Bard J, McElvania TeKippe E. Diagnosis of Bloodstream Infections in Children. Journal of clinical microbiology 2016; 54: 1418-1424
70 Guerti K, Devos H, Ieven MM. et al. Time to positivity of neonatal blood cultures: Fast and furious?. J Med Microbiol 2011; 60 Pt 4 446-453
71 Hurst MK, Yoder BA. Detection of bacteremia in young infants: Is 48 hours adequate?. The Pediatric infectious disease journal 1995; 14: 711-713
72 Jardine L, Davies MW, Faoagali J. Incubation time required for neonatal blood cultures to become positive. J Paediatr Child Health 2006; 42: 797-802
73 Vamsi SR, Bhat RY, Lewis LE. et al. Time to positivity of blood cultures in neonates. The Pediatric infectious disease journal 2014; 33: 212-214
74 Kumar Y, Qunibi M, Neal TJ. et al. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001; 85: F182-F186
75 Sarkar SS, Bhagat I, Bhatt-Mehta V. et al. Does maternal intrapartum antibiotic treatment prolong the incubation time required for blood cultures to become positive for infants with early-onset sepsis?. American journal of perinatology 2015; 32: 357-62
76 Polin RA, Watterberg K, Benitz W. et al. The conundrum of early-onset sepsis. Pediatrics 2014; 133: 1122-1123
77 Schelonka RL, Chai MK, Yoder BA. et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996; 129: 275-278
78 KRINKO. Prävention von Infektionen, die von Gefäßkathetern ausgehen: Hinweise zur Blutkulturdiagnostik. Informativer Anhang 1 zur Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2017; 60: 216-230
79 Shoji K, Komuro H, Watanabe Y. et al. The utility of anaerobic blood culture in detecting facultative anaerobic bacteremia in children. Diagnostic microbiology and infectious disease 2013; 76: 409-12
80 Yaacobi N, Bar-Meir M, Shchors I. et al. A prospective controlled trial of the optimal volume for neonatal blood cultures. The Pediatric infectious disease journal 2015; 34: 351-354
81 Patel SJ, Saiman L, Duchon JM. et al. Development of an antimicrobial stewardship intervention using a model of actionable feedback. Interdisciplinary perspectives on infectious diseases. 2012; 2012: 150367
82 Dunne Jr. WM, Tillman J, Havens PL. Assessing the need for anaerobic medium for the recovery of clinically significant blood culture isolates in children. The Pediatric infectious disease journal 1994; 13: 203-206
83 Lau YL, Hey E. Sensitivity and specificity of daily tracheal aspirate cultures in predicting organisms causing bacteremia in ventilated neonates. The Pediatric infectious disease journal 1991; 10: 290-294
84 KRINKO. Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen. Robert Koch-Institut, Infektionskrankheiten / Erreger 2013
85 Strenger V, Gschliesser T, Grisold A. et al. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum betalactamase-producing enterobacteria in hospitalised newborns. International journal of antimicrobial agents 2011; 37: 67-69
86 Downey LC, Benjamin Jr. DK, Clark RH. et al. Urinary tract infection concordance with positive blood and cerebrospinal fluid cultures in the neonatal intensive care unit. Journal of perinatology: Official journal of the California Perinatal Association 2013; 33: 302-306
87 Eldadah M, Frenkel LD, Hiatt IM. et al. Evaluation of routine lumbar punctures in newborn infants with respiratory distress syndrome. Pediatr Infect Dis J 1987; 6: 243-246
88 Garges HP, Moody MA, Cotten CM. et al. Neonatal meningitis: What is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics 2006; 117: 1094-100
89 Smith PB, Cotten CM, Garges HP. et al. A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. Journal of perinatology: Official journal of the California Perinatal Association 2006; 26: 111-114
90 Smith PB, Garges HP, Cotton CM. et al. Meningitis in preterm neonates: Importance of cerebrospinal fluid parameters. American journal of perinatology 2008; 25: 421-426
91 Edwards MS, Baker CJ, Kaplan SL et al. Bacterial meningitis in the neonate: Clinical features and diagnosis.: UpToDate. 2016 Available from
92 Malbon K, Mohan R, Nicholl R. Should a neonate with possible late onset infection always have a lumbar puncture?. Arch Dis Child 2006; 91: 75-76
93 Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clinics in perinatology 2015; 42: 29-45 vii–viii.
94 Kaul V, Harish R, Ganjoo S. et al. Importance of obtaining lumbar puncture in neonates with late onset septicemia a hospital based observational study from north-west India. Journal of clinical neonatology 2013; 2: 83-87
95 Visser VE, Hall RT. Lumbar puncture in the evaluation of suspected neonatal sepsis. J Pediatr 1980; 96: 1063-1067
96 Hendricks-Munoz KD, Shapiro DL. The role of the lumbar puncture in the admission sepsis evaluation of the premature infant. Journal of perinatology: Official journal of the California Perinatal Association 1990; 10: 60-64
97 Stoll BJ, Hansen N, Fanaroff AA. et al. To tap or not to tap: High likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004; 113: 1181-1186
98 Flidel-Rimon O, Leibovitz E, Eventov Friedman S et al. Is lumbar puncture (LP) required in every workup for suspected late-onset sepsis in neonates? Acta paediatrica (Oslo, Norway. 1992); 2011: 100: 303–304
99 Greenberg RG, Benjamin Jr. DK, Cohen-Wolkowiez M. et al. Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit. Journal of perinatology: Official journal of the California Perinatal Association 2011; 31: 425-429
100 Heath PT, Nik Yusoff NK, Baker CJ. Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F173-F178
101 Guilbert J, Levy C, Cohen R et al. Late and ultra late onset Streptococcus B meningitis: Clinical and bacteriological data over 6 years in France. Acta paediatrica (Oslo, Norway: 1992). 2010: 99: 47–51
102 Bedford H, de Louvois J, Halket S et al. Meningitis in infancy in England and Wales: Follow up at age 5 years. BMJ (Clinical research ed). 2001: 323: 533–536
103 Brook I. Spectrum and treatment of anaerobic infections. Journal of infection and chemotherapy: Official journal of the Japan Society of Chemotherapy 2016; 22: 1-13
104 de Man P, Verhoeven BA, Verbrugh HA. et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet (London, England) 2000; 355: 973-978
105 Le J, Nguyen T, Okamoto M. et al. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. The Pediatric infectious disease journal 2008; 27: 314-318
106 Manzoni P, Farina D, Leonessa M. et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006; 118: 2359-2364
107 Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129: 1006-1015
108 Clark RH, Bloom BT, Spitzer AR. et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117: 67-74
109 Muller-Pebody B, Johnson AP, Heath PT. et al. Empirical treatment of neonatal sepsis: Are the current guidelines adequate?. Arch Dis Child Fetal Neonatal Ed 2011; 96: F4-F8
110 Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. American journal of perinatology 2013; 30: 131-41.
111 Pfeifer Y. ESBL und AmpC: Beta-Laktamasen al seine Hauptursache der Cephalosporin-Resistenz bei Enterobakterien. Epidemiologisches Bulletin 2007; 28: 247-250
112 Friedman S, Shah V, Ohlsson A et al. Neonatal escherichia coli infections: Concerns regarding resistance to current therapy. Acta paediatrica (Oslo, Norway : 1992). 2000: 89: 686–689
113 Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: Evaluation of neonatal sepsis. Pediatric clinics of North America 2013; 60: 367-89
114 Müller A, Berner R, Bartmann P. Nosokomiale Sepsis bei sehr kleinen Frühgeborenen. Monatsschr Kinderheilkd 2014; 162: 411-419
115 DGPI. Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. DGPI Handbuch. Infektionen bei Kindern und Jugendlichen. 6^th ed Stuttgart: Georg Thieme Verlag; 2013
116 Yamada T, Kubota T, Nakamura M. et al. Evaluation of teicoplanin concentrations and safety analysis in neonates. International journal of antimicrobial agents 2014; 44: 458-62
117 Gausepohl HJ, Pöschl J. Leitfaden Neonatologie 2013. Heidelberg: Academic Press; 2013
118 Benjamin Jr. DK, Miller W, Garges H. et al. Bacteremia, central catheters, and neonates: When to pull the line. Pediatrics 2001; 107: 1272-1276
119 Jardine LA, Inglis GD, Davies MW. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database Syst Rev 2008; Cd006179
120 O'Grady NP, Alexander M, Burns LA. et al. Guidelines for the prevention of intravascular catheter-related infections. American journal of infection control 2011; 39 (4 Suppl 1): S1-S34
121 Biondi EA, Mischler M, Jerardi KE. et al. Blood culture time to positivity in febrile infants with bacteremia. JAMA pediatrics 2014; 168: 844-849
122 Simonsen KA, Anderson-Berry AL, Delair SF. et al. Early-onset neonatal sepsis. Clinical microbiology reviews 2014; 27: 21-47
123 Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis. J Trop Pediatr 2006; 52: 427-32
124 Hemels MA, van den Hoogen A, Verboon-Maciolek MA. et al. Shortening the antibiotic course for the treatment of neonatal coagulase-negative staphylococcal sepsis: Fine with three days?. Neonatology 2012; 101: 101-105
125 National Collaborating Centre for Women's and Children’s Health. National Institute for Health and Clinical Excellence: Guidance. Antibiotics for Neonatal Infection. London: RCOG Press 2014
126 Mukherjee A, Davidson L, Anguvaa L. et al. NICE neonatal early onset sepsis guidance: Greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed 2015; 100: F248-F249
127 Palazzi DL, Klein JO, Baker CJ. Chapter 6 - Bacterial Sepsis and Meningitis. Infectious Diseases of the Fetus and Newborn Infant. 6^th ed Philadelphia: W.B. Saunders; 2006: 247-295
128 Patel SJ, Oshodi A, Prasad P. et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. The Pediatric infectious disease journal 2009; 28: 1047-1051
129 Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. European journal of pediatrics 1996; 155: 404-409
130 Lauterbach R, Pawlik D, Kowalczyk D. et al. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial. Crit Care Med 1999; 27: 807-814
131 Pammi M, Haque KN. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2015; Cd004205
132 Shabaan AE, Nasef N, Shouman B. et al. Pentoxifylline therapy for late-onset sepsis in preterm infants: A randomized controlled trial. The Pediatric infectious disease journal 2015; 34: e143-e148
133 Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003; Cd003066.
134 Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev 2015; Cd001239
135 Brocklehurst P, Farrell B, King A. et al. Treatment of neonatal sepsis with intravenous immune globulin. The New England journal of medicine 2011; 365: 1201-1211
136 He Y, Cao L, Yu J. Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2018; 97: e11976
137 ELFIN trial investigators group. Enteral lactoferrin supplementation for very preterm infants: A randomised placebo-controlled trial. Lancet. 2019; pii: S0140-6736 18: 32221-32229 [Epub ahead of print]
138 Griffiths J, Jenkins P, Vargova M. et al. Enteral lactoferrin to prevent infection for very preterm infants: The ELFIN RCT. Health Technol Assess 2018; 22: 1-60
139 Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013; Cd000361
140 Hübler A, Hummler H. Medikamentenverzeichnis. In Jorch G, Hübler A. editors Neonatologie. 1^st ed Stuttgart: Thieme Verlagsgruppe; 2010
141 Pineda LC, Watt KM. New antibiotic dosing in infants. Clinics in perinatology 2015; 42: 167-176 ix–x.
142 Young TE, Mangum B. Neofax 2009. 22^nd ed PDR Network, LLC; 2009
143 Reynolds LF, Mailman TL, McMillan DD. Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessary. Paediatrics & child health 2012; 17: 310-312
144 Tan WH, Brown N, Kelsall AW. et al. Dose regimen for vancomycin not needing serum peak levels?. Arch Dis Child Fetal Neonatal Ed 2002; 87: F214-F216

Supplementary Material

Anhang